Sunmark and Generic Eye Drops Recalled for Manufacturing Deficiency
K.C. Pharmaceuticals is recalling 341,568 bottles of Sunmark and generic tetrahydrozoline eye drops due to manufacturing practice deficiencies. The recall affects multiple brands distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA classified this as a Class II recall due to manufacturing practice deficiencies that could affect product safety and quality. Although no illnesses or injuries have been reported, the CGMP deviation related to fill line documentation represents a risk-of-harm situation where manufacturing process integrity has been compromised.
Plain-English summary
K.C. Pharmaceuticals is recalling 341,568 bottles of Sunmark Eye Drops Original Formula (tetrahydrozoline HCl 0.05%, 0.5 FL OZ) and equivalent products distributed under multiple brand names nationwide, including DG Health, Publix, TopCare, GoodSense, Circle K, Lil' Drug Store, Rugby, Leader, CAREone, Good Neighbor Pharmacy, Walgreens, CVS Health, H-E-B, Meijer, and Best Choice.
The recall is due to good manufacturing practice (CGMP) deficiencies related to a lack of documentation of the fill line, which is essential to manufacturing process control and product quality assurance.
The affected lots are RG21F01, RG21F02, and RG21F03, all with an expiration date of June 30, 2023. Multiple UPCs and NDCs are affected across the various distributor and retailer versions of this product.
The recalled product
- Product
- SUNMARK EYE DROPS ORIGINAL FORMULA (TETRAHYDROZOLINE HCL)
- Brand
- SUNMARK EYE DROPS ORIGINAL FORMULA
- Manufacturer
- K.C. Pharmaceuticals, Inc
- Category
- Drug — Ophthalmic
- Hazard
- cgmp-deviation
- fill-control-deficiency
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: a) RG21F01
- Exp: 6/30/2023
- b) RG21F01
- c) RG21F01
- d) RG21F01
- RG21F02
- Exp 6/30/2023
- e) RG21F02
- RG21F03
- f) RG21F02
- g) RG21F02
- h) RG21F02
- i) RG21F02
- j) RG21F02
- k) RG21F02
- l) RG21F02
- m) RG21F03
- n) RG21F03
- o) RG21F03
- p) RG21F03
UPCs (20)
- 0010939167330
- 0180410000156
- 0087701149757
- 0041250829164
- 095072005565
- 041415010765
- 010939167330
- 036800036390
- 180410000156
- 194283651858
- 366715683243
- 305361217945
- 096295136456
- 041520865311
- 087701149757
- 311917200767
- 050428361313
- 041220437474
- 041250829164
- 070038470113
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27